Indian fertility experts advise caution on clinical use of new 'Non-Invasive' Embryo Genetic Test
Leading Indian fertility experts have cautioned against using non-invasive embryo genetic testing (niPGT) for routine clinical decisions. A joint review by ISAR, IFS, and ACE found the technique prone to high misdiagnosis rates, potentially leading to incorrect embryo selection or discarding. The technology, while promising, lacks sufficient evidence for clinical use.
RSS News
Economic times
0 thoughts on “Indian fertility experts advise caution on clinical use of new 'Non-Invasive' Embryo Genetic Test”
Leave a Reply
Your email address will not be published. Required fields are marked *
